Actively Recruiting
Study of Platelet-Rich Plasma Injections in Women Aged 35 to 42 with Diminished Ovarian Reserve Undergoing IVF
Led by Generation Next Fertility · Updated on 2025-02-13
230
Participants Needed
1
Research Sites
43 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether ovarian platelet-rich plasma oPRP injections can improve in vitro fertilization IVF outcomes for women aged 35 to 42 diagnosed with diminished ovarian reserve DOR, a condition associated with lower pregnancy and live birth chances. This study is a randomized, double-blind, placebo-controlled trial comparing ovarian injections of platelet-rich plasma versus serum placebo in women planning IVF with preimplantation genetic testing for aneuploidy PGT-A. Participants will undergo a baseline ultrasound and blood tests at menstruation about one month before starting IVF. Depending on follicle counts and hormone levels, patients will follow a natural, mild, or conventional IVF protocol. After ovulation is triggered, patients receive either oPRP or placebo injections under anesthesia within 72 hours. Oocyte retrieval and fertilization procedures follow standard IVF practices, with a second injection administered during retrieval. Monitoring continues between cycles, with two IVF attempts planned unless ineligible. Throughout the trial, patients will undergo routine ultrasounds, blood tests for hormone levels, and monitoring for ovarian cysts. Researchers will assess ovarian response, number of oocytes retrieved, and number of euploid embryos available for frozen embryo transfer over 12 months. The study includes safety and efficacy evaluations, with participants followed through two IVF cycles and their outcomes carefully recorded.
CONDITIONS
Brief Title
Ovarian PRP for Diminished Ovarian Reserve
Research Team
A
Alicia Broussard, PhD
J
Jesse Hade, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here